InvestorsHub Logo
Followers 30
Posts 688
Boards Moderated 0
Alias Born 07/26/2017

Re: ATLnsider post# 327889

Saturday, 11/07/2020 10:30:41 PM

Saturday, November 07, 2020 10:30:41 PM

Post# of 730883
To update the endpoints on this particular page would take someone even with limited knowledge no more than a couple of hours. Do you really think that they are so tied up that they could not do this simple task.
This inability to update a simple page with data that can be copied and pasted in, just serves to sow doubt which feeds the shorts. As Flipper has alluded are they still trying to ensnare their enemies which I doubt as they have so much more important tasks to achieve at this point.
Delivering stellar topline would be enough to crush any shorts that have targeted this company for all these years.
I agree with BSB that if the endpoints have been accepted by the FDA then NWBO owes it to to its shareholders to do the very simple task of updating the Clinical trials webpage.
Maybe Sentiment can request DI to personally oversee this very easy task which would in one swift moment support and grow the SP through to topline.
If NWBO refuse to do this task then we have to assume that the FDA has not agreed to the new endpoints.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News